Portal Pressure Predicts Outcome and Safety of Antiviral Therapy in Cirrhotic Patients With Hepatitis C Virus Infection
- 31 July 2011
- journal article
- Published by Elsevier BV in Clinical Gastroenterology and Hepatology
- Vol. 9 (7), 602-608.e1
- https://doi.org/10.1016/j.cgh.2011.03.002
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearanceNature, 2009
- Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosisHepatology, 2007
- Peginterferon alfa-2b and ribavirin in patients with hepatitis C virus and decompensated cirrhosis: A controlled studyJournal of Hepatology, 2007
- American Gastroenterological Association Medical Position Statement on the Management of Hepatitis CGastroenterology, 2006
- Predicting sustained virological responses in chronic hepatitis C patients treated with peginterferon alfa-2a (40KD)/ribavirinJournal of Hepatology, 2005
- Suppression of haematopoiesis during therapy of chronic hepatitis C with different interferon mono and combination therapy regimensGut, 2005
- Sampling variability of liver fibrosis in chronic hepatitis CHepatology, 2003
- Treatment of patients with hepatitis C and cirrhosisHepatology, 2002
- HypersplenismEuropean Journal of Gastroenterology & Hepatology, 2001
- An algorithm for the grading of activity in chronic hepatitis CHepatology, 1996